Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label linagliptin. Show all posts
Showing posts with label linagliptin. Show all posts
Monday, June 11, 2012

Lilly, Boehringer Ingelheim announce results from linagliptin Phase III trial on T2D

›
 In continuation of my update on Linagliptin Results of the one Phase III study presented (Poster No. 999-P) showed ...
Sunday, February 5, 2012

FDA Approves Jentadueto ((linagliptin/metformin hydrochloride)).....

›
In continuation of my update on  linagliptin and metformin hydrochloride U.S. Food and Drug Administration (FDA) has approved  Jentadue...
Wednesday, October 5, 2011

Health Canada approves Trajenta (linagliptin) for type 2 diabetes

›
Linagliptin (below structure, BI-1356 , trade name Tradjenta ) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment ...
Tuesday, September 20, 2011

›
We know that, Linagliptin ( BI-1356 , trade name Tradjenta ) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.